nuvaxovid - Search News

News

Novavax, COVID-19 and Nuvaxovid

PharmExec · 3h

FDA Grants Full Approval to Novavax’s Nuvaxovid COVID-19 Vaccine

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

Clinical Pain Advisor · 5h

FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

FDA Approves Novavax COVID Vaccine With Restricted Use

The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from COVID can also get the shot.

1d

FDA’s Conditions on NVAX’s COVID-19 Jab

The FDA grants full approval to Novavax's protein-based COVID-19 vaccine after nearly a two-month delay, albeit with some new ...

Schaeffer's Investment Research1d

Novavax Stock Soars on FDA Approval for COVID Vaccine

In the options pits, NVAX has already seen quadruple the overall options volume it typically sees in an entire session, with ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results